AI-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis

April 10, 2024 updated by: Yanqing Li, Shandong University

Artificial Intelligence-assisted White Light Endoscopy to Identify the Kimura-Takemoto Classification of Atrophic Gastritis to Achieve Gastric Cancer Risk Assessment

Grading endoscopic atrophy according to the Kimura-Takemoto classification can assess the risk of gastric neoplasia development. However, the false negative rate of chronic atrophic gastritis is high due to the varying diagnostic standardization and diagnostic experience and levels of endoscopists. Therefore, this study aims to develop an AI model to identify the Kimura-Takemoto classification.

Study Overview

Detailed Description

Grading endoscopic atrophy according to the Kimura-Takemoto classification can assess the risk of gastric neoplasia development. The higher the score, the more severe the degree of atrophic gastritis. However, the false negative rate of chronic atrophic gastritis is high due to the varying diagnostic standardization and diagnostic experience and levels of endoscopists. Therefore, this study aims to develop an AI model to identify the Kimura-Takemoto classification of atrophic gastritis to achieve gastric cancer risk assessment.

Study Type

Observational

Enrollment (Estimated)

1500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Shandong
      • Shangdong, Shandong, China, 250012
        • Recruiting
        • Department of Gastrology, QiLu Hospital, Shandong University
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Consecutive patients who receive the gastrointestinal endoscopy examination and screened that fulfill the eligibility criteria at Qilu Hospital,Shandong University,Linyi County People's Hospital will be enrolled into the study

Description

Inclusion Criteria:

Patients aged 18-80 years who undergo the white light endoscope examination Informed consent form provided by the patient.

Exclusion Criteria:

  1. patients with severe cardiac, cerebral, pulmonary or renal dysfunction or psychiatric;
  2. disorders who cannot participate in gastroscopy;
  3. Patients with progressive gastric cancer;
  4. low quality pictures;
  5. patients with previous surgical procedures on the stomach or esophageal;
  6. patients who refuse to sign the informed consent form;

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Chronic atrophic gastritis observed by white light endoscope
Get pictures from gastric antrum,gastric angle,lesser curvature of gastric body, cardia, gastric fundus, greater curvature of gastric body by white light endoscope
Endosopists and AI will assess the Kimura-Takemoto classification independently when the patients is eligible.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Accuracy of AI model to diagnose the Kimura-Takemoto classification
Time Frame: 2 years
Accuracy of AI model to diagnose the Kimura-Takemoto classification
2 years
Sensitivity of AI model to diagnose the Kimura-Takemoto classification
Time Frame: 2 years
Sensitivity of AI model to diagnose the Kimura-Takemoto classification
2 years
Specificity of AI model to diagnose the Kimura-Takemoto classification
Time Frame: 2 years
Specificity of AI model to diagnose the Kimura-Takemoto classification
2 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The MIOU value of AI model in semantic segmentation of endoscopic atrophy picture
Time Frame: 2 years
The MIOU value of AI model in semantic segmentation of endoscopic atrophy picture
2 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: yanqing li, MD,PHD, Qilu Hospital, Shandong University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 1, 2023

Primary Completion (Estimated)

December 31, 2024

Study Completion (Estimated)

December 31, 2024

Study Registration Dates

First Submitted

June 14, 2023

First Submitted That Met QC Criteria

June 14, 2023

First Posted (Actual)

June 23, 2023

Study Record Updates

Last Update Posted (Actual)

April 12, 2024

Last Update Submitted That Met QC Criteria

April 10, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Artificial Intelligence

Clinical Trials on Diagnostic Test: The diagnosis of Artificial Intelligence and endosopists

Subscribe